North Star Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

North Star Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$453K	Sell	727 -10	-1%	-$6.81K	0.02%	260
2026 Q1	$569K	Hold	737	–	–	0.02%	233
2025 Q4	$569K	Hold	737	–	–	0.02%	223
2025 Q3	$414K	Hold	737	–	–	0.02%	249
2025 Q2	$387K	Buy	+737	New	+$411K	0.02%	250
2024 Q4	–	Sell	-277	Closed	-$291K	–	331
2024 Q3	$291K	Hold	277	–	–	0.01%	263
2024 Q2	$291K	Sell	277 -1	-0.4%	-$969	0.01%	259
2024 Q1	$268K	Hold	278	–	–	0.01%	269
2023 Q4	$244K	Hold	278	–	–	0.01%	269
2023 Q3	$229K	Buy	+278	New	+$218K	0.01%	271
2023 Q2	–	Sell	-281	Closed	-$231K	–	304
2023 Q1	$231K	Buy	281 +1	+0.4%	+$754	0.01%	270
2022 Q4	$202K	Buy	+280	New	+$207K	0.01%	290

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

North Star Asset Management's REGN Position: Q2 2026 in Review

North Star Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q2 2026, selling an estimated $6.81K and leaving 727 shares worth $453K. The position accounts for 0.02% of the portfolio, ranked #260.

North Star Asset Management first reported a position in REGN in Q4 2022 and has held it in 12 quarters since. The position peaked at $569K in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

North Star Asset Management held 727 shares of Regeneron Pharmaceuticals worth $453K as of Q2 2026.
North Star Asset Management sold 10 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.81K.
Regeneron Pharmaceuticals made up 0.02% of North Star Asset Management's portfolio in Q2 2026, its #260 holding.
North Star Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
North Star Asset Management's Regeneron Pharmaceuticals position peaked at $569K in Q1 2026.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.